Targeting Wnt/β-catenin signaling using XAV939 nanoparticles in tumor microenvironment-conditioned macrophages promote immunogenicity

Targeting Wnt/β-catenin signaling using XAV939 nanoparticles in tumor microenvironment-conditioned macrophages promote immunogenicity

The aberrant activation of Wnt/β-catenin signaling in tumor cells and immune cells in the tumor microenvironment (TME) promotes malignant transformation, metastasis, immune evasion, and resistance to cancer treatments. The increased Wnt ligand expression in TME activates β-catenin signaling in antig...

Full description

Bibliographic Details
Main Authors:	Chetan Pundkar, Ferrin Antony, Xuejia Kang, Amarjit Mishra, R. Jayachandra Babu, Pengyu Chen, Feng Li, Amol Suryawanshi
Format:	Article
Language:	English
Published:	Elsevier 2023-06-01
Series:	Heliyon
Subjects:	Tumor microenvironment β-catenin XAV939 Nanoparticle Wnt Tumor-associated macrophages
Online Access:	http://www.sciencedirect.com/science/article/pii/S2405844023038951

Similar Items

Ocular Wnt/β-Catenin Pathway Inhibitor XAV939-Loaded Liposomes for Treating Alkali-Burned Corneal Wound and Neovascularization
by: Yueyang Zhong, et al.
Published: (2021-10-01)

Inhibition of Wnt signalling pathway by XAV939 enhances radiosensitivity in human cervical cancer HeLa cells
by: Jinhua Zhang, et al.
Published: (2020-01-01)

Wnt inhibitor XAV-939 promote the adipogenic differentiation of dental pulp stem cells
by: WEN Jun, et al.
Published: (2016-08-01)

Docetaxel Resistance in Castration-Resistant Prostate Cancer: Transcriptomic Determinants and the Effect of Inhibiting Wnt/β-Catenin Signaling by XAV939
by: Elena Pudova, et al.
Published: (2022-10-01)

Modelling of a targeted nanotherapeutic ‘stroma’ to deliver the cytokine LIF, or XAV939, a potent inhibitor of Wnt–β-catenin signalling, for use in human fetal dopaminergic grafts in Parkinson’s disease
by: Jing-Wei Zhao, et al.
Published: (2014-10-01)

Low Dose of Paclitaxel Combined with XAV939 Attenuates Metastasis, Angiogenesis and Growth in Breast Cancer by Suppressing Wnt Signaling
by: Dattatrya Shetti, et al.
Published: (2019-08-01)

Qici Sanling decoction suppresses bladder cancer growth by inhibiting the Wnt/Β-catenin pathway
by: Hua Gong, et al.
Published: (2019-01-01)

Ubiquitin C-Terminal Hydrolase L5 (UCHL5) Accelerates the Growth of Endometrial Cancer via Activating the Wnt/β-Catenin Signaling Pathway
by: Da Liu, et al.
Published: (2020-06-01)

Corrigendum: Ubiquitin C-Terminal hydrolase L5 (UCHL5) accelerates the growth of endometrial cancer via activating the Wnt/β-catenin signaling pathway
by: Da Liu, et al.
Published: (2022-08-01)

Canonical WNT/β-Catenin Signaling Plays a Subordinate Role in Rhabdomyosarcomas
by: Nada Ragab, et al.
Published: (2018-12-01)

β-catenin/Wnt signaling controls progenitor fate in the developing and regenerating zebrafish retina
by: Meyers Jason R, et al.
Published: (2012-08-01)

Targeting liver cancer stem cell through EpCAM therapy targeted with chemotherapy endorse enhanced progression in hepatocellular carcinoma
by: Vasanthakumar Sekar, et al.
Published: (2023-06-01)

Wnt signaling blockade is essential for maintaining the pluripotency of chicken embryonic stem cells
by: Ryota Kajihara, et al.
Published: (2024-02-01)

Antibacterial and Zebrafish-based Screening for Wnt Signal Inhibitory Activities of Syzygium polycephaloides (C.B. Robb. Merr.) Bark Extracts
by: Rolly Garnace Fuentes, et al.
Published: (2021-05-01)

The overexpression of actin related protein 2/3 complex subunit 1B(ARPC1B) promotes the ovarian cancer progression via activation of the Wnt/β-catenin signaling pathway
by: Junning Huang, et al.
Published: (2023-05-01)

Wnt Signaling Cascade in Dendritic Cells and Regulation of Anti-tumor Immunity
by: Amol Suryawanshi, et al.
Published: (2020-02-01)

Upregulation of long noncoding RNA RP4 exacerbates hypoxia injury in cardiomyocytes through regulating miR-939/Bnip3/Wnt/β-catenin pathway
by: Jingfeng Rong, et al.
Published: (2019-12-01)

The Wnt/β-catenin signaling pathway in the tumor microenvironment of hepatocellular carcinoma
by: Kaiting Wang, et al.
Published: (2022-03-01)

Inhibition of Wnt/β-Catenin Signaling in Neuroendocrine Tumors In Vitro: Antitumoral Effects
by: Xi-Feng Jin, et al.
Published: (2020-02-01)

Gene Expression Comparison between the Lymph Node-Positive and -Negative Reveals a Peculiar Immune Microenvironment Signature and a Theranostic Role for WNT Targeting in Pancreatic Ductal Adenocarcinoma: A Pilot Study
by: Antonella Argentiero, et al.
Published: (2019-07-01)

Two Distinct Characteristics of Immune Microenvironment in Human Hepatocellular Carcinoma with Wnt/β-Catenin Mutations
by: Tomoko Aoki, et al.
Published: (2023-10-01)

Inhibitory Effect of a Tankyrase Inhibitor on Mechanical Stress-Induced Protease Expression in Human Articular Chondrocytes
by: Yoshifumi Hotta, et al.
Published: (2024-01-01)

New Advances in Canonical Wnt/β-Catenin Signaling in Cancer
by: Wen X, et al.
Published: (2020-08-01)

Wnt/β-catenin signaling pathway in the tumor progression of adrenocortical carcinoma
by: Yanghao Tai, et al.
Published: (2024-01-01)

Low-Grade Ovarian Stromal Tumors with Genetic Alterations of the Wnt/β-Catenin Pathway That Is Crucial in Ovarian Follicle Development and Regulation
by: Gloria Zhang, et al.
Published: (2022-11-01)

Thymol Isolated from Thymus vulgaris L. Inhibits Colorectal Cancer Cell Growth and Metastasis by Suppressing the Wnt/β-Catenin Pathway
by: Zeng Q, et al.
Published: (2020-07-01)

Sanguinarine Regulates Tumor-Associated Macrophages to Prevent Lung Cancer Angiogenesis Through the WNT/β-Catenin Pathway
by: Yajing Cui, et al.
Published: (2022-06-01)

Wnt Signaling Inhibitors and Their Promising Role in Tumor Treatment
by: Nives Pećina-Šlaus, et al.
Published: (2023-04-01)

Wnt/β-Catenin Signaling and Resistance to Immune Checkpoint Inhibitors: From Non-Small-Cell Lung Cancer to Other Cancers
by: Satoshi Muto, et al.
Published: (2023-01-01)

WNT: an unexpected tumor suppressor in medulloblastoma
by: Branavan Manoranjan, et al.
Published: (2020-11-01)

Dickkopf-Related Protein 2 is Epigenetically Inactivated and Suppresses Colorectal Cancer Growth and Tumor Metastasis by Antagonizing Wnt/β-Catenin Signaling
by: Can Wang, et al.
Published: (2017-03-01)

Wnt/beta-catenin signaling in vertebrate eye development
by: Naoko Fujimura
Published: (2016-11-01)

A Review of the Role of Wnt in Cancer Immunomodulation
by: Whitney N. Goldsberry, et al.
Published: (2019-06-01)

Cinnamaldehyde Inhibits the Function of Osteosarcoma by Suppressing the Wnt/β-Catenin and PI3K/Akt Signaling Pathways
by: Huang Y, et al.
Published: (2020-10-01)

Bioactivity Studies of Hesperidin and XAV939
by: Ahmed E. Fazary, et al.
Published: (2021-07-01)

Cinnamaldehyde Inhibits the Function of Osteosarcoma by Suppressing the Wnt/β-Catenin and PI3K/Akt Signaling Pathways [Retraction]
by: Huang Y, et al.
Published: (2024-04-01)

Targeting Oncogenic Wnt/β-Catenin Signaling in Adrenocortical Carcinoma Disrupts ECM Expression and Impairs Tumor Growth
by: Morgan K. Penny, et al.
Published: (2023-07-01)

Modulating PKCα Activity to Target Wnt/β-Catenin Signaling in Colon Cancer
by: Sébastien Dupasquier, et al.
Published: (2019-05-01)

Sevoflurane inhibits cholangiocarcinoma via Wnt/β-catenin signaling pathway
by: Hui Cheng, et al.
Published: (2023-08-01)

Targeting Wnt/β-Catenin Pathway for Developing Therapies for Hair Loss
by: Bu Young Choi
Published: (2020-07-01)